World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
23717
World Ranking
12898
National Ranking
401

Overview

Yi Ba is affiliated with the Beijing Institute of Genomics in China and has an extensive record of publications predominantly in the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans significant contributions to oncology, pulmonary and respiratory medicine, molecular biology, surgery, and cancer research.

The scientist's work focuses on several main topics, including:

  • Gastric Cancer Management and Outcomes
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Treatments and Mutations
  • Esophageal Cancer Research and Treatment
  • Gastrointestinal Tumor Research and Treatment
  • Pancreatic and Hepatic Oncology Research

Yi Ba's frequent publication venues emphasize oncology and cancer research, with multiple papers appearing in:

  • Journal of Clinical Oncology
  • Research Square
  • Cancer Biology and Medicine
  • Cancer Research
  • Annals of Oncology

The scientist has collaborated often with several coauthors, including Ting Deng, Yuxian Bai, Hongli Li, Haiyang Zhang, and Yuchong Yang.

Significant recent publications include:

  • "CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer," 2020, Molecular Cancer
  • "Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma," 2021, JAMA
  • "Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study," 2020, The Lancet Oncology
  • "Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer," 2020, Molecular Oncology
  • "Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer," 2022, Advanced Science

Yi Ba's research contributes extensively to understanding cancer mechanisms such as chemo-resistance and ferroptosis, as well as clinical outcomes related to immunotherapy and chemotherapy across several types of cancer. Their work intersects molecular oncology and clinical interventions, addressing complex issues in gastrointestinal and thoracic oncology.

Best Publications

  • Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

    Xi Chen;Yi Ba;Lijia Ma;Lijia Ma;Xing Cai

  • Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration

    Yujing Zhang;Danqing Liu;Xi Chen;Jing Li

  • Exogenous plant MIR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA

    Lin Zhang;Dongxia Hou;Xi Chen;Donghai Li

  • Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

    Jin Li;Shukui Qin;Jianming Xu;Jianping Xiong

  • CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.

    Haiyang Zhang;Ting Deng;Rui Liu;Tao Ning

  • Role of miR-143 targeting KRAS in colorectal tumorigenesis

    X. Chen;X. Guo;H. Zhang;H. Zhang;Y. Xiang

  • A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis

    Rui Liu;Chunni Zhang;Zhibin Hu;Gou Li;Gou Li

  • Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial

    Huiyan Luo;Huiyan Luo;Jin Lu;Yuxian Bai;Teng Mao

  • Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.

    Jing Huang;Jianming Xu;Yun Chen;Wu Zhuang

  • Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer

    Rui Liu;Rui Liu;Xi Chen;Xi Chen;Yiqi Du;Weiyan Yao

  • Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

    Haiyang Zhang;Ting Deng;Rui Liu;Ming Bai

  • Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.

    Xinyi Wang;Haiyang Zhang;Haiou Yang;Ming Bai

  • Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432.

    F. Wang;X.L. Wei;F.H. Wang;N. Xu

  • Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

    Xi Chen;Zhibin Hu;Wenjing Wang;Yi Ba

  • Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7.

    Haiyang Zhang;Ting Deng;Shaohua Ge;Ying Liu

  • Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway.

    Haiyang Zhang;Lei Zhu;Ming Bai;Ying Liu

  • Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer

    Xinyi Wang;Haiyang Zhang;Ming Bai;Tao Ning

  • Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells.

    Haiou Yang;Haiyang Zhang;Shaohua Ge;Tao Ning

  • miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer

    Xin Yan;Xin Yan;Xi Chen;Hongwei Liang;Ting Deng

  • Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

    Zhong Zhen Guan;Jian Ming Xu;Rong Cheng Luo;Feng Yi Feng

Frequent Co-Authors

Chen-Yu Zhang
Chen-Yu Zhang Nanjing University
Ke Zen
Ke Zen Nanjing University
Xi Chen
Xi Chen Nanjing University
Rui-Hua Xu
Rui-Hua Xu Sun Yat-sen University
Yongqian Shu
Yongqian Shu Nanjing Medical University
Jianming Xu
Jianming Xu Zhejiang University
Li Zhang
Li Zhang Sun Yat-sen University
Jifeng Feng
Jifeng Feng Nanjing Medical University
Zhibin Hu
Zhibin Hu Nanjing Medical University
Satoshi Morita
Satoshi Morita Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA can open numerous doors to rewarding health science careers. For those interested in the intersection of healthcare, technology, and data, medical coding is a promising path. The medical.coding salary remains competitive, making it an attractive option for recent graduates.

Medical billing and coding jobs are in high demand due to a growing need for accurate health information management. Learn more about job trends and market needs by reading is medical billing and coding in demand.

If you’re considering a fast, affordable route to start or advance your health information career, review the affordable online him programs now widely available.

For students interested in applying biochemistry or biology expertise to health and wellness, an online nutrition masters may lead to careers in dietetics, research, or public health.

These related degrees and pathways highlight how online study can support your growth in biology, biochemistry, and allied health fields.

Best Scientists Citing Yi Ba

Trending Scientists